Skip to main content

Table 3 The effects of endoscopic therapies on variceal recurrence after esophageal variceal eradication

From: The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

 

EVL group

(n = 54)

EIS group

(n = 80)

EVL + EIS group

(n = 19)

P value

Course number of endoscopic treatment course to variceal eradication

1.9 ± 0.7

3.2 ± 1.2a

3.4 ± 1.6a

0.00

Median time of variceal recurrence(month)

10

13a

12

0.01

EUS findings

 diameter of peri-ECV(mm)

2.9 ± 1.4

3.4 ± 1.5

2.9 ± 1.1

0.14

 diameter of PFV(mm)

1.44 ± 1.5

0.9 ± 1.5

1.0 ± 1.3

0.15

 existence or not of PFV(Y/N,n)

29/25

24/56a

6/13

0.01

 diameter of para-ECV(mm)

6.2 ± 2.1

6.3 ± 2.3

6.3 ± 2.4

0.83

Esophageal stenosis(Y/N,n)

0/54

9/71a

0/19

0.01

Child-Pugh grade(n,%)

0.21

 A

29, 53.7

57, 71.3

10, 52.6

 

 B

20, 37.0

16, 20

7, 36.9

 C

5, 9.3

7, 8.7

2, 10.5

Child-Pugh score

7.2 ± 2.1

6.7 ± 1.7

7.2 ± 1.9

0.36

Portal vein embolus(Y/N, n)

10/44

24/56

4/15

0.29

With liver cancer (n,%)

7, 13.0

9, 11.3

3,15.8

0.85

Unknown causes for cirrhosis

0

2

1

  1. aCompared with EVL group